Evidence map›Paper›PMID 32466340›Full record

ArticleInternational journal of molecular sciences2020

Insights into the FMNAT Active Site of FAD Synthase: Aromaticity is Essential for Flavin Binding and Catalysis.

Ana Serrano, Sonia Arilla-Luna, Milagros Medina

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ana SerranoDepartment of Biochemistry and Molecular and Cellular Biology, Faculty of Sciences, and Institute of Biocomputation and Physics of Complex Systems (Joint Units: BIFI-IQFR and GBsC-CSIC), University of Zaragoza, E-50009 Zaragoza, Spain.
Sonia Arilla-LunaDepartment of Biochemistry and Molecular and Cellular Biology, Faculty of Sciences, and Institute of Biocomputation and Physics of Complex Systems (Joint Units: BIFI-IQFR and GBsC-CSIC), University of Zaragoza, E-50009 Zaragoza, Spain.
Milagros MedinaCentro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, E-28040 Madrid, Spain.ORCID 0000-0001-8743-0182
Universidad de Zaragoza · ESCentro de Investigaciones Biológicas Margarita Salas · ES

Funding

Government of Aragon-FEDER E35_20RSpanish Agencia Estatal de Investigación and Fondo Europeo de Desarrollo Regional BIO2016-75183-P AEI/FEDER
6 · The paper itself

Abstract

The last step in the biosynthesis of flavin adenine dinucleotide (FAD) is considered a target for the design of antimicrobial drugs because it is carried out by two non-homologous proteins in eukaryotic and prokaryotic organisms. Monofunctional FMN: adenylyltransferases (FMNAT) in Eukarya and FMNAT modules of bifunctional FAD synthases (FADS) in Prokarya belong to different structural families with dissimilar chemistry and binding modes for the substrates. In this study, we analyzed the relevance of the hydrophobic environment of the flavin isoalloxazine in the FMNAT active site of

Indexed as

Catalytic DomainBacterial ProteinsCorynebacteriumDinitrocresolsHydrophobic and Hydrophilic InteractionsMutationNucleotidyltransferasesPhenylalanineProtein BindingTyrosine4,6-dinitro-o-cresolBacterial ProteinsDinitrocresolsFMN adenylyltransferaseNucleotidyltransferasesPhenylalanineTyrosinearomatic residuesbindingeukaryotic ATP:FMN:adenylyltransferaseflavin biosynthesisisoalloxazineisothermal titration calorimetryprokaryotic FAD synthaserational mutagenesissteady-state kinetics

Identifiers

PMID32466340
PMCPMC7279473
OpenAlexW3027283037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.